Datwyler accelerates its profitable growth.
Despite the ongoing uncertainty caused by the pandemic, Datwyler has increased its forecasts for the year as a whole for revenue and EBIT margin to over CHF 1’150 million and above 16%, respectively.
Datwyler StarterPack™ makes its North American debut at CPHI North America.
The company will also showcase NeoFlex™ plungers and DuraCoat™ combiseals, which enable drug developers to protect the integrity of injectables throughout development to distribution.
Datwyler to offer 2-day virtual training course with the Parenteral Drug Association.
From August 30-31, Datwyler will be hosting a 2-day virtual training course with the Parenteral Drug Association (PDA) on Characteristics of Pharmaceutical Elastomers and Aluminum Seals in Parenteral Packaging Systems.
CPhI North America 2021.
We are thrilled to announce the return of our tradeshows in North America.
Sterilization Techniques for Parenteral Packaging.
Successful community projects in India.
For years, Datwyler has been supporting the inhabitants of the surrounding villages through various community projects, thereby having a positive influence on the local environs.
Datwyler expands material capabilities to support industry shift to e-mobility.
Datwyler Introduces the SoftPulse™ Long.
Datwyler Half-Year Results 2021
Anti-counterfeiting: integrated electronics enter the fight.
Datwyler recognized as pivotol partner for COVID-19 vaccine providers.
Datwyler is founding member of Alliance to Zero.
As a founding member of the Alliance to Zero Datwyler aims net zero emissions across the pharmaceutical supply chain.